ReviewPharmaceutics2023

An Insight on the Possible Association between Inflammatory Bowel Disease and Biologic Therapy with IL-17 Inhibitors in Psoriasis Patients.

Olguța Anca Orzan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.